CLINICAL_TRIALS
trial_result
· 2018-03-07
Clinical Trial Update: A Study to Investigate Bio Product Laboratory Ltd (BPL's) Factor X in the Prophylaxis of Bleeding in Children <12 Years [Phase 3]
Summary
A Phase 3 clinical trial evaluating Factor X concentrate from Bio Products Laboratory for prophylaxis of bleeding in children under 12 with Factor X deficiency …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bio Products Laboratory | Conditions: Factor X Deficiency | Phase 3 | Status: COMPLETED | Results posted: 2018-03-07